Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.21.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:    
Research and development $ 435 $ 1,373
Selling, general and administrative 4,961 7,938
Total operating expenses 5,396 9,311
Loss from operations (5,396) (9,311)
Other income (expense):    
Interest expense (2) (1,234)
Loss on coversion of notes (22)
Loss on extinguishment of debt (18)
Change in fair value of warrant liability 123
Total other expense (2) (1,151)
Net loss $ (5,398) $ (10,462)
Net loss per share, basic and diluted: (in Dollars per share) $ (0.38) $ (1.81)
Weighted average shares outstanding, basic and diluted: (in Shares) 14,315,142 5,780,844